Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Annals of Internal Medicine

• Publication date

  1990-04-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.7326/0003-4819-112-8-590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Dysmyelopoietic syndromes a search for prognostic factors in 193 patients

  2006cited by this paper
• The National Marrow Donor Program: how it works, accomplishments to date.

  1989cited by this paper
• Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine.

  1988cited by this paper
• Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disorders.

  1988cited by this paper
• Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.

  1988cited by this paper
• Regimen-related toxicity in patients undergoing bone marrow transplantation.

  1988cited by this paper
• Partially matched bone marrow transplantation in patients with myelodysplastic syndromes.

  1988cited by this paper
• Treatment of preleukemic syndromes with marrow transplantation

  1987cited by this paper
• Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes.

  1987cited by this paper
• Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.

  1987cited by this paper
• Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen

  1987cited by this paper
• Marrow transplantation for the treatment of chronic myelogenous leukemia.

  1986cited by this paper
• Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

  1986cited by this paper
• A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes.

  1986cited by this paper
• Hematologic and cytogenetic remission of 5q-refractory anemia after syngeneic bone marrow transplantation.

  1986cited by this paper
• Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.

  1986cited by this paper
• Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside.

  1985cited by this paper
• Danazol therapy in myelodysplasia.

  1985cited by this paper
• Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

  1985cited by this paper
• Dysmyelopoietic syndrome. Current concepts.

  1984cited by this paper
• Allogeneic marrow transplantation in the treatment of preleukemia.

  1984cited by this paper
• The smoldering myeloid leukemic states: clinical and biologic features.

  1983cited by this paper
• Response of preleukemic syndromes to continuous infusion of low-dose cytarabine.

  1983cited by this paper
• Restoration of normal hematopoiesis by bone marrow ablation and allogeneic marrow transplantation in a case of Hodgkin's disease therapy-related preleukemia.

  1983cited by this paper
• Proposals for the classification of the myelodysplastic syndromes

  1982cited by this paper
• CYCLOSPORIN A AND METHOTREXATE IN CANINE MARROW TRANSPLANTATION: ENGRAFTMENT, GRAFT‐VERSUS-HOST DISEASE, AND INDUCTION OF TOLERANCE

  1982cited by this paper
• Refractory anemia with excess of blast cells: Prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients

  1979cited by this paper
• The preleukemic syndrome (hemopoietic dysplasia)

  1978cited by this paper
• The preleukemic syndrome: clinical and laboratory features, natural course, and management.

  1976cited by this paper
• Preleukemia: The hematologie syndrome preceding acute leukemia

  1973cited by this paper
• Quantitation of bone marrow reticulin--a normal range.

  1971cited by this paper

• Atlogencic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey by the Leukaemia Work ing Party of the European Bone Marrow Transplantation Group

  2017cites this paper
• Up-Front Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Arising from the Myelodysplastic Syndrome

  2014cites this paper
• Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes

  2013cites this paper
• Therapeutic Modalities for Patients with Lower-Risk Myelodysplastic Syndromes: Current Options and Future Directions

  2011cites this paper
• Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem‐cell transplantation: Report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo

  2011cites this paper
• Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study

  2010cites this paper
• Myelodysplastic Syndromes (MDS)

  2010cites this paper
• Allogeneic Transplantation for Myelodysplastic Syndromes

  2010cites this paper
• Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity

  2010cites this paper
• Hypomethylating agent induction therapy followed by hematopoietic cell transplantation is feasible in patients with myelodysplastic syndromes.

  2010cites this paper
• Role of hematopoietic stem cell transplantation in acute myelogenous leukemia and myelodysplastic syndrome.

  2009cites this paper
• The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.

  2009cites this paper
• La greffe de cellules souches hématopoïétiques

  2009cites this paper
• WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

  2008cites this paper
• WHO CLASSIFICATION AND WPSS PREDICT POST-TRANSPLANT OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: RESULTS OF A RETROSPEC

  2008cites this paper
• Autologous and allogeneic stem cell transplantation for myelodysplastic syndrome.

  2007cites this paper
• Bone marrow and hemopoietic stem cell transplantation

  2007cites this paper
• Human herpesvirus-6 hepatitis associated with cyclosporine-A encephalitis after bone marrow transplantation for chronic myeloid leukemia.

  2006cites this paper
• Hemopoietic cell transplantation as curative therapy of myelodysplastic syndromes and myeloproliferative disorders.

  2006cites this paper
• Hemopoietic Cell Transplantation

  2006cites this paper
• High-dose cyclophosphamide as an effective therapy for a patient with refractory multiple myeloma relapsing after autologous stem cell transplantation.

  2005cites this paper
• Myelodisplastik Sendromda Tedavi TREATMENT OF MYELODYSPLASTIC SYNDROME

  2005cites this paper
• The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup study

  2005cites this paper
• Monitoring treatment efficiency in MDS at the molecular level; possibilities now and in the future

  2004cites this paper
• Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies

  2004cites this paper
• Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience

  2004cites this paper
• Hematopoietic cell transplantation for adult patients with myelodysplastic syndromes and myeloproliferative disorders.

  2003cites this paper
• Molecular studies in myelodysplastic syndromes

  2003influential citation
• Hemopoietic cell transplantation for the myelodysplastic syndromes.

  2003cites this paper
• The Effects of Kami-kihi-to (Jia-Wei-Gui-Pi-Tang) on Hematological Findings and Systemic States in a Patient with Hemochromatosis after Blood Transfusions for Myelodysplastic Syndrome

  2003cites this paper
• Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST)

  2003cites this paper
• Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study

  2003cites this paper
• Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis

  2002cites this paper
• Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS.

  2001cites this paper
• Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

  2001cites this paper
• Myelodysplastic syndromes: recent advances.

  2001cites this paper
• Myelodysplastic Syndromes Myelodysplastic syndromes : recent advances

  2001cites this paper
• Genotypically nonidentical related donors for transplantation of patients with myelodysplastic syndromes: comparison with unrelated donor transplantation and autologous stem cell transplantation

  2001cites this paper
• Intensive Chemotherapy Followed by Stem Cell Transplantation for the Treatment of Myelodysplastic Syndromes

  2001cites this paper
• Haematopoietic stem cell transplantation for patients with myelo‐dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

  2000influential citation
• Allogeneic bone marrow transplantation improves the outcome of de novo AML with trilineage dysplasia (AML-TLD)

  2000cites this paper
• Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.

  2000cites this paper
• Intensive treatment strategies in patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukemia.

  2000cites this paper
• Myelodysplastic Syndromes in Childhood

  2000cites this paper
• Limited erythropoietic response to combined treatment with recombinant human interleukin 3 and erythropoietin in myelodysplastic syndrome.

  1999cites this paper
• Allogeneic hematopoietic stem cell transplantation for acute leukemia, chronic leukemia, and myelodysplasia.

  1999cites this paper
• Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation.

  1998cites this paper
• Recent Advances in Myelodysplastic Syndromes

  1998cites this paper
• The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t

  1998cites this paper
• Bone marrow transplantation for myelodysplasia in adults and children: when and who?

  1998cites this paper
• Randomized clinical study comparing aggressive chemotherapy with or without G‐CSF support for high‐risk myelodysplastic syndromes or secondary acute myeloid leukaemia evolving from MDS

  1998cites this paper
• #639 Bone marrow transplantation for children less than two years of age with acute myelogenous leukemia or myelodysplastic syndrome

  1998cites this paper
• Etiopathogeny, prognosis and therapy of myelodysplastic syndromes.

  1997cites this paper
• Myelodysplastic Syndromes or Leukemia Following MDS Treated with Allogeneic Bone Marrow Transplantation: A Survey of the Working Party on Chronic Leukemia of the European Cooperative Group for Blood and Marrow Transplantation

  1997cites this paper
• Indications and timing of allogeneic bone marrow transplantation in myelodysplastic syndromes.

  1997cites this paper
• Therapy-related myeloid leukemia.

  1996cites this paper
• Feasibility of peripheral blood progenitor cell harvest and transplantation in patients with poor‐risk myelodysplastic syndromes

  1996cites this paper
• Treatment and prognostic factors in myelodysplastic syndromes.

  1996cites this paper
• Treatment of high‐risk myelodysplastic syndromes with lymphoblastoid alpha interferon

  1996cites this paper
• Myelodysplastic syndromes in the elderly: the role of growth factors in management.

  1996cites this paper
• Projecting disease when death is likely.

  1996cites this paper
• The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer

  1996cites this paper
• Myelodysplastic (preleukemia) syndromes: the bone marrow factory failure problem.

  1995cites this paper
• Myelodysplastic syndromes: the pediatric point of view.

  1995cites this paper
• Impact of patient weight on non-relapse mortality after marrow transplantation.

  1995cites this paper
• Is aggressive chemotherapy the best choice for patients with acute nonlymphocytic leukemia after myelodysplastic syndromes?

  1995cites this paper
• Myelodysplastic syndromes--a population-based study on transformation and survival.

  1995cites this paper
• The Role of Bone Marrow Transplantation in the Treatment of Myelodysplastic Syndromes

  1995cites this paper
• A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia.

  1995cites this paper
• Myelodysplastic Syndromes: Treatment Indication and Choice of Therapy

  1994cites this paper
• Low dose melphalan for myelodysplastic syndrome

  1994cites this paper
• Clinical Use of Growth Factors in the Myelodysplastic Syndromes

  1994cites this paper
• New treatment approaches for myelodysplastic syndrome and secondary leukaemias

  1994cites this paper
• Allogeneic marrow transplantation for myelodysplastic syndrome complicating autologous bone marrow transplantation.

  1994cites this paper
• Myelodysplastic syndromes in childhood: description of seven cases

  1994cites this paper
• Myelodysplastic Syndromes: Response to Aggressive Chemotherapy and Prognostic Factors for Treatment Outcome

  1994cites this paper
• Myelodysplastic syndromes in childhood--classification, epidemiology, and treatment.

  1994cites this paper
• Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.

  1993cites this paper
• Bone Marrow Transplantation: A Review

  1993cites this paper
• Treatment of myelodysplastic syndromes with daily oral idarubicin. A phase I–II study

  1993cites this paper
• Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus.

  1993cites this paper
• Karyotypic analysis in primary myelodysplastic syndromes.

  1993cites this paper
• Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes.

  1993cites this paper
• Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome.

  1993cites this paper
• Treatment of therapy-related leukemia and myelodysplastic syndrome.

  1993cites this paper
• Proportional hazards (Cox) regression

  1993cites this paper
• All-trans retinoic acid in patients with myelodysplastic syndromes: results of a pilot study.

  1993cites this paper
• Poor prognosis acute myelogenous leukemia.

  1993cites this paper
• BONE MARROW TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME AND SECONDARY LEUKAEMIAS

  1993influential citation
• MANAGEMENT OF MYELODYSPLASTIC SYNDROMES

  1993cites this paper
• Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

  1993cites this paper
• Prognosis and therapy of myelodysplastic syndromes.

  1993cites this paper
• The treatment of acute myeloid leukaemia preceded by the myelodysplastic syndrome.

  1992cites this paper
• Myelodysplastic syndromes (refractory anemia). A perspective of the biologic, clinical, and therapeutic issues.

  1992cites this paper
• Case report: alternation therapy with antileukemic agents and recombinant human granulocyte colony-stimulating factor for RAEB in transformation.

  1992cites this paper
• Myelodysplastische Erkrankungen im Kindesalter

  1992cites this paper
• The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: a phase-III intergroup study

  1992cites this paper
• Treatment of myelodysplastic syndromes with hematopoietic growth factors.

  1992cites this paper
• Experience in pediatric myelodysplastic syndromes.

  1992cites this paper
• In vitro growth modulation by L-ascorbic acid of colony-forming cells from bone marrow of patients with myelodysplastic syndromes.

  1992influential citation